×
Brooks Laboratories

BROOKS

Price
Micro Cap
₹413 Cr.
Brooks Laboratories Limited is a pharmaceutical contract research and manufacturing services company specializing in critical care products in Parental Section. It offers a wide range of products including Beta Lactam, Cephalosporin, Carbapenems, Dry powder Injectables, Ampoules, Liquid vials, Dry Syrups, and Tablets. The company also manufactures products … More
Brooks Laboratories Limited is a pharmaceutical contract research and manufacturing services company specializing in critical care products in Parental Section. It offers a wide range of products including Beta Lactam, Cephalosporin, Carbapenems, Dry powder Injectables, Ampoules, Liquid vials, Dry Syrups, and Tablets. The company also manufactures products for third-party companies like Zydus Cadila, Alembic, Intas, and Wockhardt. Less
Brooks Laboratories Limited is a pharmaceutical contract research and manufacturing services compan… More
Brooks Laboratories Limited is a pharmaceutical contract research and manufacturing services company specializing in critical care products in Parental Section. It offers a wide range of products including Beta Lactam, Cephalosporin, Carbapenems, Dry powder Injectables, Ampoules, Liquid vials, Dry Syrups, and Tablets. The company also manufactures products for third-party companies like Zydus Cadila, Alembic, Intas, and Wockhardt. Less
Low
73.25
52W Range
High
199
PE
--
Sector PE
25.37
P/B
6.98
Div.Yield
--
ROE
-29.87%
EBIDTA
104
ROCE
3.56
EPS
-1.74

  • Share Price

  • Financials

  • Revenue mix

  • Shareholdings

  • Peers

  • Forensics

Niche index constructed using market cap and revenue exposure of companies in this sector
  • 5D
  • 1M
  • 6M
  • YTD
  • 1Y
  • 5Y
  • MAX

This data is currently unavailable for this company.

  • Summary

  • Profit & Loss

  • Balance sheet

  • Cashflow

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly
(In Cr.)
(In Cr.)

This data is currently unavailable for this company.
Financial Ratio's
(In %)
Detailed P&L Report
(In Cr.)
Detailed Balance Sheet
Financial Year (In Cr.)
Detailed Cash Flow

  • Product wise

  • Location wise

BROOKS
Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    BROOKS
    Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    More Info
    Shareholdings
    Holders
    Detailed Shareholdings

    This data is currently unavailable for this company.

    Peers
    Detailed Peers
    Forensics
    View Detailed Forensics

    Recent events

    • News

    • Corporate Actions

    Brooks Laboratories Approves Fund Raise Of Up To 750 Million Rupees

    Dec 11, 2024

    Brooks Laboratories Approved Raising Of Funds

    Jan 24, 2024

    Brooks Laboratories To Consider Raising Of Funds

    Jan 17, 2024

    Brooks Laboratories To Consider And Approve Fund Raising Through Rights Issue

    Jan 16, 2024

    Brooks Laboratories Fixes 115.8 Million Rupees As Right Issue Size

    Jul 18, 2023

    Events:

    Announcement Date
    Feb 13, 2025
    Announcement Date
    Nov 09, 2024
    Announcement Date
    Aug 28, 2024
    Announcement Date
    Aug 14, 2024
    Announcement Date
    Jan 31, 2024
    Announcement Date
    Nov 09, 2023
    Announcement Date
    Aug 31, 2023
    Announcement Date
    Aug 10, 2023

    Rights

    1 rights eligible for every 16 shares held.
    Ex Date
    Jul 28, 2023
    Announcement Date
    May 29, 2023
    Announcement Date
    Feb 14, 2023
    Announcement Date
    Nov 14, 2022
    Announcement Date
    Sep 06, 2022
    Announcement Date
    Aug 10, 2022
    Announcement Date
    May 30, 2022
    Announcement Date
    Feb 14, 2022
    Announcement Date
    Nov 12, 2021
    Announcement Date
    Aug 13, 2021
    Announcement Date
    Jun 30, 2021
    Announcement Date
    Feb 11, 2021
    Announcement Date
    Nov 12, 2020
    Announcement Date
    Sep 15, 2020
    Announcement Date
    Jul 21, 2020
    Announcement Date
    Jun 30, 2020
    Announcement Date
    Feb 14, 2020

    Rights

    9 rights eligible for every 20 shares held.
    Ex Date
    Feb 11, 2020

    More Micro Cap Ideas

    See similar 'Micro' cap companies with recent activity

    Promoter Buying

    Companies where the promoters are bullish

    Detailed List

    Capex

    Companies investing on expansion

    Detailed List

    Superstar Investor

    Companies where well known investors have invested

    Detailed List